Truist Securities has reiterated its “Hold” rating for Molina Healthcare (MOH) but significantly lowered its price target from $190.00 to $145.00. This adjustment follows similar price target reductions by other major financial institutions earlier in February 2026. Despite the lowered targets, the average analyst forecast still implies a 17.00% upside from the current price, while GuruFocus estimates a much larger upside based on its calculated GF Value.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Truist Securities Lowers Price Target for Molina Healthcare (MOH)
Truist Securities has reiterated its “Hold” rating for Molina Healthcare (MOH) but significantly lowered its price target from $190.00 to $145.00. This adjustment follows similar price target reductions by other major financial institutions earlier in February 2026. Despite the lowered targets, the average analyst forecast still implies a 17.00% upside from the current price, while GuruFocus estimates a much larger upside based on its calculated GF Value.